Correction: In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma
Cazzamalli S, Figueras Agustí E, Pethő L, Borbély AN, Steinkühler C, Neri D, Sewald N (2018)
ACS Omega 3(12): 16743-16743.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Cazzamalli, Samuele;
Figueras Agustí, EduardUniBi;
Pethő, Lilla;
Borbély, Adina NoémiUniBi;
Steinkühler, Christian;
Neri, Dario;
Sewald, NorbertUniBi 
Einrichtung
Erscheinungsjahr
2018
Zeitschriftentitel
ACS Omega
Band
3
Ausgabe
12
Seite(n)
16743-16743
eISSN
2470-1343
Page URI
https://pub.uni-bielefeld.de/record/2944897
Zitieren
Cazzamalli S, Figueras Agustí E, Pethő L, et al. Correction: In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma. ACS Omega. 2018;3(12):16743-16743.
Cazzamalli, S., Figueras Agustí, E., Pethő, L., Borbély, A. N., Steinkühler, C., Neri, D., & Sewald, N. (2018). Correction: In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma. ACS Omega, 3(12), 16743-16743. doi:10.1021/acsomega.8b03183
Cazzamalli, Samuele, Figueras Agustí, Eduard, Pethő, Lilla, Borbély, Adina Noémi, Steinkühler, Christian, Neri, Dario, and Sewald, Norbert. 2018. “Correction: In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma”. ACS Omega 3 (12): 16743-16743.
Cazzamalli, S., Figueras Agustí, E., Pethő, L., Borbély, A. N., Steinkühler, C., Neri, D., and Sewald, N. (2018). Correction: In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma. ACS Omega 3, 16743-16743.
Cazzamalli, S., et al., 2018. Correction: In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma. ACS Omega, 3(12), p 16743-16743.
S. Cazzamalli, et al., “Correction: In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma”, ACS Omega, vol. 3, 2018, pp. 16743-16743.
Cazzamalli, S., Figueras Agustí, E., Pethő, L., Borbély, A.N., Steinkühler, C., Neri, D., Sewald, N.: Correction: In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma. ACS Omega. 3, 16743-16743 (2018).
Cazzamalli, Samuele, Figueras Agustí, Eduard, Pethő, Lilla, Borbély, Adina Noémi, Steinkühler, Christian, Neri, Dario, and Sewald, Norbert. “Correction: In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma”. ACS Omega 3.12 (2018): 16743-16743.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 31458304
PubMed | Europe PMC
Suchen in
Google Scholar